Tuesday 12 March 2019
Royal Society of Medicine
1 Wimpole Street
CPD - Applied for
Compassion use has been rarely out of the news in the last year. Whilst recent high profile cases have involved children, compassionate use is by no means restricted to paediatrics, and stakeholders have much to learn from each other.
The idea that a treatment that has not yet completed clinical trials can be made available in specified circumstances for patients in dire need is an appealing but problematic one. ’When should this ‘work-around’ be applied and when should it not?’ is a question that troubles patients and their families, clinicians, ethics committee members, regulators and the developers of those treatments.
This meeting will offer much-needed education on (and discussion of) the concept of ‘compassionate use,’ at the boundary between medical research and clinical practice. We anticipate that the day will be of educational interest to clinicians, members of legal and regulatory professions, patient advocates, ethicists, and members of the press.
Speakers will address the issue from a number of relevant perspectives including: clinical, legal and regulatory, ethical, the media and commerce. The meeting is particularly relevant training for anyone who may potentially be involved in discussing, negotiating or reporting a ‘compassionate-use’ case.
RSM members: £36 - £94
Non-members: £60 - £160
Registration, tea and coffee
Dr Paquita De Zulueta, President, Open Section, Royal Society of Medicine
Dr Andrew Papanikitas
An introduction to ‘Compassionate use’ and its close relatives in healthcare settings
Dr Nicola Stingelin
Encountering ‘Compassionate Use’ in Healthcare
Dr Ketan Shah, Consultant Clinical Oncologist, Company Name Oxford University Hospitals NHS Foundation Trust
Tea and coffee break
Compassionate Use and the law in the UK
James Lawford Davies, Partner, Hempsons, London
What are the ethical debates around ‘Compassionate use’ in healthcare?
Professor Dominic Wilkinson, Director and Professor of Medical Ethics, University of Oxford, Consultant in newborn intensive care, John Radcliffe Hospital
Dr Andrew Papanikitas, Nicola Stingelin, James Lawford Davies, Ketan Shah, Dominic Wilkinson
Dr Nicola Stingelin, Independent Research Ethics Advisor
The law in action - how do compassionate use cases unfold?
Vikram Sachdeva, QC
Compassionate use – which ethics committee and why?
Dr Anne-Marie Slowther, Reader in Clinical Ethics, Warwick Medical School and Clinical Ethicisit, University Hospitals Coventry and Warwickshire NHS Trust
Tea and coffee break
Compassionate use - implications for industry
Dr Rav Seeruthen, Medical Director, Roche UK
Compassionate use – politics, public opinion and the media
Mr Tom Sheldon, Science Media Centre
Chair Dr Nicola Stingelin, Mr Vikram Sachdeva, Professor Anne Slowther, Dr Rav Seeruthun, Mr Tom Sheldon
Close of meeting and online evaluations